Last reviewed · How we verify
Alcohol, Ethyl
At a glance
| Generic name | Alcohol, Ethyl |
|---|---|
| Also known as | Alcohol |
| Sponsor | Brown University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
- A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder (PHASE2)
- Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis (NA)
- Tirzepatide in MetALD (PHASE2)
- NIAAA Natural History Protocol
- Hepatic Lipid Metabolism-Alcohol Use Disorder
- Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
- Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Alcohol, Ethyl CI brief — competitive landscape report
- Alcohol, Ethyl updates RSS · CI watch RSS
- Brown University portfolio CI